By Therapeutic Area

Metastatic & Oligo-Progressive Disease Market Analysis

Cross-industry research covering Metastatic & Oligo-Progressive Disease across 1 market reportspanning Medical Devices & Surgical Navigation.

1 Reports
1 Industries

Reports Covering Metastatic & Oligo-Progressive Disease

Breast Lesion Localization Methods Market to Reach USD 1.42B by 2033 at 8.3% CAGR

Medical Devices & Surgical Navigation·Market: USD 0.74 Billion (2025)·CAGR: 8.3%

Local ablative therapy for oligo-progression in metastatic breast cancer, studied in the Netherlands Cancer Institute's COSMO trial (nct:NCT05301881), requires precise lesion targeting. This remains a niche localization context but grows as systemic therapy improvements extend metastatic patients' survival and increase the frequency of surgical or ablative interventions.

3%

Market Share

6.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments